Development of the technology of a lyophilized powder for preparing the solution for injections based on bee venom
DOI:
https://doi.org/10.24959/nphj.19.9Keywords:
solution for injections, lyophilized bee venom powder, technologyAbstract
Cancer remains one of the most common causes of death among the population of most countries of the world. In this aspect, special attention is paid to new medicinal substances from bee products, including bee venom, which numerous components stimulate and strengthen the body as a whole, and at the same time its protective and restorative functions.
Aim. To develop the technology of a lyophilized powder for preparing the solution for injections based on bee venom.
Materials and methods. When creating and organizing industrial production of medicines based on bee venom the lyophilization was proposed as a technological method. It provides a long-term storage of drugs and is used to obtain stable freeze-dried powders, in particular for preparing solutions for injections (e.g. antibiotics, etc.) The main stage of the experimental research was development of the technology for obtaining a lyophilizate for injections. For this purpose, the conditions for freezing the solution based on bee venom were studied. The determination of the temperature and method of freezing the solution was carried out sequentially, the effect of the freezing duration on the quality of the final product and the process of sublimation drying of the drug were studied.
Results and discussion. In order to determine the eutectic temperature having a specific value for each substance when freezing the solution based on bee venom we used the thermal method considered to be the most simple and advantageous. In the process of studying the effect of the freezing rate on the structure of the drug the solution based on bee venom was poured in 1 ml ampoules or in vials and frozen on the shelves of the sublimation unit to -50 °C; -60 °С, applying slow (stage-by-stage) and rapid freezing. The effect of the freezing method on the quality of a lyophilizate for injections from bee venom was assessed according to the following indicators: the appearance of the preparation, transparency, moisture, solubility, pH, the quantitative content of bee venom (in the cell), the quantitative content of lidocaine hydrochloride.
Conclusions. The technology of a freeze-dried powder for preparing the solution for injections based on bee venom has been developed, namely: the optimal freeze-drying regime has been studied and determined. According to the results of the research the quality indicators of the drug have been determined.
References
Markova, M. V., Piontkovska, O. V., Kuzhel, I. R. (2012). Ukrainskyi Visnyk psykhonevrolohii, 20 (4(73)), 86–91.
Desaive, P., & Ronson, A. (2008). Stress spectrum disorders in oncology. Current Opinion in Oncology, 20 (4), 378–385. https://doi.org/10.1097/cco.0b013e328302166a
Tikhonov, A. I., Shpychak, O. S., Skrypnik–Tkhonov, R. I. (2015). Current status of the apipreparation the national university of pharmacy. Modern directions in chemistry, biology, pharmacy and biotechnology: International scientific congress. Lviv, 190–195.
Tikhonov, A. I., & Bondarchuk, L. I. (2010). Iad pchelinyi v farmatcii i meditcine (teoriia, tekh nologiia, meditcinskoe primenenie) : Monografiia. Kharkiv : Original, 280.
Florea, A., & Crăciun, C. (2013). Bee Venom Induced In Vivo Ultrastructural Reactions of Cells Involved in the Bone Marrow Erythropoiesis and of Circulating Red Blood Cells. Microscopy and Microanalysis, 19 (2), 393–405. https://doi.org/10.1017/s1431927612014195
Kasper, J. C., & Friess, W. (2011). The freezing step in lyophilization : Physico–chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. European Journal of Pharmaceutics and Biopharmaceutics, 78 (2), 248–263. https://doi.org/10.1016/j.ejpb.2011.03.010
Tikhonov, A. I., Bondarchuk, L. I., Tichonowa, S. A. (2011). Jad pszczeli w farmacji i medycynie (teoria, technologia, zastosowanie lecznicze). Myslenice : Apipol–Farma, 240.
Yarnykh, T. H., Shpychak, O. S. (2006). Aktualni pytannia farmatsevtychnoi ta medychnoi nauky ta praktyky. Zaporizhzhia : ZDMU, 2(XV), 275–280.
Skrypnyk–Tykhonov, R. I., Syrota, P. S. (2014). Tekhnolohichni ta biofarmatsevtychni aspekty stvorennia likarskykh preparativ riznoi napravlenosti dii : materialy I Mizhnar. nauk.–prakt. internet–konf. Kharkiv : NFaU, 157–158.
Skrypnyk–Tykhonov, R. I., Yur’ieva, H. B. (2011). Aktualni pytannia stvorennia novykh likarskykh zasobiv : materialy vseukr. nauk.–prakt. konf. stud. ta molodykh vchenykh, prysviach. 140–richchiu z dnia narodzh. d–ra farmats. ta khim. nauk, prof. Mykoly Ovksentiiovycha Valiashka. Kharkiv, 224–225.
Skrypnyk–Tychonov, R. I., Syrota P. S. (2015). Aplication of high frmagments for fluids in progress chromatography methods for determining the quality of bee venov. Topical issues of new drugs development: abstracts of international scientific and practical conference of young scientists and student. Kharkiv : NFaU, 223.
Filippo, Nazo. (2005). Osnovi sublimatsionnoi sushki. VOS Edwards Pharmaceutical Systems : Mezhdunar. konf. Moscow, 2–47.
Hottot, A., Andrieu, J., & Vessot, S. (2007). Sublimation Kinetics during Freeze-Drying of Pharmaceutical Protein Formulation. Drying Technology, 25 (5), 753–758. https://doi.org/10.1080/07373930701370126
Skrypnyk–Tykhonov, R. I., Syrota, P. S., Tykhonov, O. I., Almakaieva, L. H., Naumenok, L. H. (2015). Farmatsevtychnyi zhurnal, 3, 45–52.
Kamath, L. (2006). Practical Technologies for Lyophilization. Genetic Engineering & Biotechnology News, 26 (20), 1–4.
Bakhtin, I. A. (2012). Sovershenstvovanie protcessa sublimatcionnogo vysushivaniia lekarstvennykh preparatov. Extended abstract of candidate’s thesis. Perm, 26.
Nezhuta, A. A. (2001). Biotekhnologiia, 6, 59–67.
Gubin, M. M., Umarov, S. Z. (2006). Farmatciia, 2, 25–29.
Moiseeva, E. V. (2005). Farmatciia, 2, 20–24.
Tekhnologiia i standartizatciia lekarstv. (2000). Kharkiv: IG “RIREG”, 2, 369–373.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
